First-line chemotherapy treatment of advanced non-small-cell lung cancer: Does cisplatin versus carboplatin make a difference?

Journal of Thoracic Oncology

Volumn 9, Issue 11, 2014, Pages e82-

  Tiseo, Marcello ^a   Ardizzoni, Andrea ^a   Boni, Luca ^b  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; PEMETREXED; ANTINEOPLASTIC AGENT;

ACUTE KIDNEY FAILURE; ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL TRIAL (TOPIC); COMORBIDITY; COMPARATIVE STUDY; CYTODIAGNOSIS; DEHYDRATION; DISEASE ASSOCIATION; DRUG EFFICACY; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; INFECTION COMPLICATION; LETTER; META ANALYSIS (TOPIC); NAUSEA; NEPHROTOXICITY; NEUTROPENIA; NON SMALL CELL LUNG CANCER; OUTPATIENT CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT RESPONSE; VETERANS HEALTH; VOMITING; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; LUNG NEOPLASMS; MALE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; FEMALE; HUMANS; LUNG NEOPLASMS; MALE;

EID: 84925705992     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000272     Document Type: Letter

References (4)

1. Santana-Davila R, Szabo A, Arce-Lara C, Williams CD, Kelley MJ, Whittle J. Cisplatin versus carboplatin-based regimens for the treatment of patients with metastatic lung cancer. an analysis of Veterans Health Administration data. J Thorac Oncol 2014;9:702-709.
2. Ardizzoni A, Boni L, Tiseo M, et al.; CISCA (CISplatin versus CArboplatin) Metaanalysis Group. Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst 2007;99:847-857.
3. Ou SH, Zell JA. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies. J Thorac Oncol 2009;4:1202-1211.
4. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008;26:3543-3551.